Predictive Value of Expression of ERCC 1 and GST-p for 5-Fluorouracil/Oxaliplatin Chemotherapy in Advanced Colorectal Cancer - Concepedia

Concepedia

Publication | Closed Access

Predictive Value of Expression of ERCC 1 and GST-p for 5-Fluorouracil/Oxaliplatin Chemotherapy in Advanced Colorectal Cancer

27

Citations

0

References

2011

Year

Eiji Noda, Kiyoshi Maeda, Toru Inoue, Shinya Fukunaga, Hisashi Nagahara, Masatsune Shibutani, Ryosuke Amano, Bunzo Nakata, Hiroaki Tanaka, Kazuya Muguruma,

Hepatogastroenterology

Abstract

Immunohistochemical studies for ERCC-1 and GST-p may be useful in prediction of the response to 5-fluorouracil/oxaliplatin chemotherapy in advanced colorectal cancer patients.